India likely to allow export of Sputnik Light COVID shot this month, say sources

India is likely to allow the export of domestically produced doses of Russia’s Sputnik Light COVID-19 vaccine this month, as the shot has yet to be approved in India, two sources with knowledge of the matter told Reuters.

Local media have reported that Indian drugmaker Hetero has already manufactured 2 million doses of the single-shot vaccine, for whose approval the country’s drug regulator has sought a separate “immune-bridging clinical trial” in its residents.

Sputnik Light exports are expected to begin from this month,” said one of the sources, both of whom declined to be named. “Light is not an approved vaccine in India and stocks are available. There’s pressure on the government to export.”

Hetero and Dr. Reddy’s Laboratories, the Indian partner of Russian sovereign wealth fund RDIF that markets the Sputnik range of vaccines globally, declined to comment. India’s health ministry and RDIF did not respond to a request for comment.

Light is the first of two differing components of the two-dose Sputnik V vaccine that has been authorised for emergency use in India and elsewhere. Light has also been approved in many countries but Indian experts want to know if the single-dose vaccine would work well on Indians.

India has administered 907,766 Sputnik V doses so far, out of 839.1 million shots given in total.

India will resume exports of approved COVID vaccines, mainly a licensed version of the AstraZeneca shot, in the October quarter after shipments were banned in April when infections surged in the country. Output has jumped since then.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 180 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 268 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra